{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T10:33:03Z","timestamp":1768991583963,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Bonn"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract\n<\/jats:title>\n          <jats:sec>\n            <jats:title>Background\n<\/jats:title>\n            <jats:p>Radiation dermatitis (RD) is the most common side effect of breast irradiation, yet only few potent preventative and therapeutic options are available. Following encouraging results from a phase 1 and 2 trial on the topical use of non-invasive physical plasma (NIPP), a very well-tolerated physical treatment option to promote tissue regeneration generated from ambient air, we now present the study protocol for a planned phase 3 trial.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this randomised double-blind placebo-controlled trial, patients with breast cancer will be randomised (1:1) to receive either 120\u00a0s of NIPP or sham treatment with an identical device daily during hypofractionated breast irradiation following breast-conserving surgery. Standard skin care with urea lotion will be applied twice daily to the whole breast by all patients. Acute skin toxicity will be assessed weekly and includes clinician- (CTCAE v5.0) and patient-reported (modified RISRAS), and objective (spectrophotometry) assessments. The trial has started enrolment in the first quarter of 2024 and is projected to recruit 140 patients over 36\u00a0months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>This randomised controlled trial will recruit a homogeneous patient collective in terms of RD risk and aims to unequivocally establish the impact of NIPP on RD by employing a robust trial design, incorporating both the patient\u2019s perspective and validated objective outcome measures. If the addition of NIPP proves useful, it might reduce both physical and psychological distress caused by RD in numerous breast cancer patients and beyond.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>German Clinical Trial Registry DRKS00032560 (January 9th 2024).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13063-025-08806-w","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T09:18:24Z","timestamp":1742375904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Non-invasive physical plasma for preventing radiation dermatitis in breast cancer: study protocol for a phase 3 randomised double-blind placebo-controlled trial (NIPP-RD III)"],"prefix":"10.1186","volume":"26","author":[{"given":"Cas Stefaan","family":"Dejonckheere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian Philipp","family":"Layer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo Renato","family":"Sarria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shari","family":"Wiegreffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Renate","family":"Glasmacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youn\u00e8ss","family":"Nour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Scafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Mu\u0308dder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Anzb\u00f6ck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank Anton","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias Bernhard","family":"Stope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard Christopher","family":"Schmeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Gkika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"8806_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"key":"8806_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2021.0459","volume":"83","author":"C Katsura","year":"2022","unstructured":"Katsura C, Ogunmwonyi I, Kankam HK, Saha S. Breast cancer: presentation, investigation and management. Br J Hosp Med (Lond). 2022;83:1\u20137. https:\/\/doi.org\/10.12968\/hmed.2021.0459.","journal-title":"Br J Hosp Med (Lond)"},{"key":"8806_CR3","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1001\/jamaoncol.2015.2666","volume":"1","author":"SF Shaitelman","year":"2015","unstructured":"Shaitelman SF, Schlembach PJ, Arzu I, Ballo M, Bloom ES, Buchholz D, et al. Acute and short-term toxic effects of conventionally fractionated vs. hypofractionated whole-breast radiation: a randomized clinical trial. JAMA Oncol. 2015;1:931\u201341. https:\/\/doi.org\/10.1001\/jamaoncol.2015.2666.","journal-title":"JAMA Oncol"},{"key":"8806_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.radonc.2020.02.018","volume":"146","author":"LC Schmeel","year":"2020","unstructured":"Schmeel LC, Koch D, Schmeel FC, R\u00f6hner F, Schoroth F, B\u00fccheler BM, et al. Acute radiation-induced skin toxicity in hypofractionated vs. conventional whole-breast irradiation: an objective, randomized multicenter assessment using spectrophotometry. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2020;146:172\u20139. https:\/\/doi.org\/10.1016\/j.radonc.2020.02.018.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"8806_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jpainsymman.2019.03.017","volume":"58","author":"MDA Fuzissaki","year":"2019","unstructured":"Fuzissaki MDA, Paiva CE, de Oliveira MA, Lajolo Canto PP, de Paiva Maia YC. The impact of radiodermatitis on breast cancer patients\u2019 quality of life during radiotherapy: a prospective cohort study. J Pain Symptom Manage. 2019;58:92-99.e1. https:\/\/doi.org\/10.1016\/j.jpainsymman.2019.03.017.","journal-title":"J Pain Symptom Manage"},{"key":"8806_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jaad.2019.03.011","volume":"86","author":"A Rzepecki","year":"2022","unstructured":"Rzepecki A, Birnbaum M, Ohri N, Daily J, Fox J, Bodner W, et al. Characterizing the effects of radiation dermatitis on quality of life: a prospective survey-based study. J Am Acad Dermatol. 2022;86:161\u20133. https:\/\/doi.org\/10.1016\/j.jaad.2019.03.011.","journal-title":"J Am Acad Dermatol"},{"key":"8806_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-022-06829-6","author":"S Finkelstein","year":"2022","unstructured":"Finkelstein S, Kanee L, Behroozian T, Wolf JR, van den Hurk C, Chow E, et al. Comparison of clinical practice guidelines on radiation dermatitis: a narrative review. Support Care Cancer. 2022. https:\/\/doi.org\/10.1007\/s00520-022-06829-6.","journal-title":"Support Care Cancer"},{"key":"8806_CR8","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1016\/S1470-2045(23)00067-0","volume":"24","author":"T Behroozian","year":"2023","unstructured":"Behroozian T, Bonomo P, Patel P, Kanee L, Finkelstein S, van den Hurk C, et al. Multinational Association of Supportive Care in Cancer (MASCC) clinical practice guidelines for the prevention and management of acute radiation dermatitis: international Delphi consensus-based recommendations. Lancet Oncol. 2023;24:e172\u201385. https:\/\/doi.org\/10.1016\/S1470-2045(23)00067-0.","journal-title":"Lancet Oncol"},{"key":"8806_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2023.07.001","author":"CS Dejonckheere","year":"2023","unstructured":"Dejonckheere CS, Dejonckheere E, Layer JP, Layer K, Sarria GR, Koch D, et al. Barrier films for the prevention of acute radiation dermatitis in breast cancer: a systematic review and meta-analysis of randomised controlled trials. The Breast. 2023. https:\/\/doi.org\/10.1016\/j.breast.2023.07.001.","journal-title":"The Breast"},{"key":"8806_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-023-02074-w","author":"K Layer","year":"2023","unstructured":"Layer K, Layer JP, Glasmacher AR, Sarria GR, B\u00f6hner AMC, Layer YL, et al. Risk assessment, surveillance, and nonpharmaceutical prevention of acute radiation dermatitis: results of a multicentric survey among the German-speaking radiation oncology community. Strahlenther Onkol. 2023. https:\/\/doi.org\/10.1007\/s00066-023-02074-w.","journal-title":"Strahlenther Onkol"},{"key":"8806_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.15279","author":"JP Layer","year":"2023","unstructured":"Layer JP, Layer K, Glasmacher AR, Sarria GR, B\u00f6hner AMC, Layer YL, et al. Pharmaceutical management of acute radiation dermatitis in the German-speaking radiation oncology community. J Dtsch Dermatol Ges. 2023. https:\/\/doi.org\/10.1111\/ddg.15279.","journal-title":"J Dtsch Dermatol Ges"},{"key":"8806_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/ddg.13373","volume":"16","author":"L Gan","year":"2018","unstructured":"Gan L, Zhang S, Poorun D, Liu D, Lu X, He M, et al. Medical applications of nonthermal atmospheric pressure plasma in dermatology. J Der Dtsch Dermatologischen Gesellschaft. 2018;16:7\u201313. https:\/\/doi.org\/10.1111\/ddg.13373.","journal-title":"J Der Dtsch Dermatologischen Gesellschaft"},{"key":"8806_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.10411","volume":"3","author":"B Stratmann","year":"2020","unstructured":"Stratmann B, Costea T-C, Nolte C, Hiller J, Schmidt J, Reindel J, et al. Effect of cold atmospheric plasma therapy vs. standard therapy placebo on wound healing in patients with diabetic foot ulcers: a randomized clinical trial. JAMA Netw Open. 2020;3: e2010411. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.10411.","journal-title":"JAMA Netw Open"},{"key":"8806_CR14","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.21873\/invivo.12143","volume":"34","author":"K Kletschkus","year":"2020","unstructured":"Kletschkus K, Haralambiev L, Mustea A, Bekeschus S, Stope MB. Review of innovative physical therapy methods: introduction to the principles of cold physical plasma. In Vivo. 2020;34:3103\u20137. https:\/\/doi.org\/10.21873\/invivo.12143.","journal-title":"In Vivo"},{"key":"8806_CR15","doi-asserted-by":"publisher","unstructured":"Stope MB. Plasma oncology - physical plasma as innovative tumor therapy. J Cancer Biol. 2020;1:53\u20136. https:\/\/doi.org\/10.46439\/cancerbiology.1.010.","DOI":"10.46439\/cancerbiology.1.010"},{"key":"8806_CR16","doi-asserted-by":"publisher","first-page":"79501","DOI":"10.1088\/1361-6595\/aaced9","volume":"27","author":"R Brandenburg","year":"2018","unstructured":"Brandenburg R. Dielectric barrier discharges: progress on plasma sources and on the understanding of regimes and single filaments. Plasma Sources Sci Technol. 2018;27:79501. https:\/\/doi.org\/10.1088\/1361-6595\/aaced9.","journal-title":"Plasma Sources Sci Technol"},{"key":"8806_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3873928","volume":"2019","author":"T Bernhardt","year":"2019","unstructured":"Bernhardt T, Semmler ML, Sch\u00e4fer M, Bekeschus S, Emmert S, Boeckmann L. Plasma medicine: applications of cold atmospheric pressure plasma in dermatology. Oxid Med Cell Longev. 2019;2019: 3873928. https:\/\/doi.org\/10.1155\/2019\/3873928.","journal-title":"Oxid Med Cell Longev"},{"key":"8806_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/iwj.12999","volume":"16","author":"O Assadian","year":"2019","unstructured":"Assadian O, Ousey KJ, Daeschlein G, Kramer A, Parker C, Tanner J, et al. Effects and safety of atmospheric low-temperature plasma on bacterial reduction in chronic wounds and wound size reduction: a systematic review and meta-analysis. Int Wound J. 2019;16:103\u201311. https:\/\/doi.org\/10.1111\/iwj.12999.","journal-title":"Int Wound J"},{"key":"8806_CR19","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00253-021-11166-5","volume":"105","author":"B Boekema","year":"2021","unstructured":"Boekema B, Stoop M, Vlig M, van Liempt J, Sobota A, Ulrich M, et al. Antibacterial and safety tests of a flexible cold atmospheric plasma device for the stimulation of wound healing. Appl Microbiol Biotechnol. 2021;105:2057\u201370. https:\/\/doi.org\/10.1007\/s00253-021-11166-5.","journal-title":"Appl Microbiol Biotechnol"},{"key":"8806_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.21873\/invivo.13413","volume":"38","author":"N Gelbrich","year":"2024","unstructured":"Gelbrich N, Muhtadi R, Scherthan H, Stope MB. Short-term effects of non-invasive physical plasma treatment on genomic stability. In Vivo. 2024;38:82\u20139. https:\/\/doi.org\/10.21873\/invivo.13413.","journal-title":"In Vivo"},{"key":"8806_CR21","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.0454","author":"Y Kost","year":"2023","unstructured":"Kost Y, Rzepecki AK, Deutsch A, Birnbaum MR, Ohri N, Hosgood HD, et al. Association of Staphylococcus aureus colonization with severity of acute radiation dermatitis in patients with breast or head and neck cancer. JAMA Oncol. 2023. https:\/\/doi.org\/10.1001\/jamaoncol.2023.0454.","journal-title":"JAMA Oncol"},{"key":"8806_CR22","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.6533","author":"C H\u00fclp\u00fcsch","year":"2024","unstructured":"H\u00fclp\u00fcsch C, Neumann AU, Reiger M, Fischer JC, de Tomassi A, Hammel G, et al. Association of skin microbiome dynamics with radiodermatitis in patients with breast cancer. JAMA Oncol. 2024. https:\/\/doi.org\/10.1001\/jamaoncol.2023.6533.","journal-title":"JAMA Oncol"},{"key":"8806_CR23","doi-asserted-by":"publisher","first-page":"LBA12003 \u2013LBA12","DOI":"10.1200\/JCO.2022.40.17_suppl.LBA12003","volume":"40","author":"Y Kost","year":"2022","unstructured":"Kost Y, Mieczkowska K, Deutsch A, Nazarian R, Muskat A, Hosgood D, et al. Bacterial decolonization to prevent acute radiation dermatitis: a randomised controlled trial. J Clin Oncol. 2022;40:LBA12003\u2013LBA12003. https:\/\/doi.org\/10.1200\/JCO.2022.40.17_suppl.LBA12003.","journal-title":"J Clin Oncol"},{"key":"8806_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.4062\/biomolther.2014.105","volume":"22","author":"B Haertel","year":"2014","unstructured":"Haertel B, von Woedtke T, Weltmann K-D, Lindequist U. Non-thermal atmospheric-pressure plasma possible application in wound healing. Biomol Ther (Seoul). 2014;22:477\u201390. https:\/\/doi.org\/10.4062\/biomolther.2014.105.","journal-title":"Biomol Ther (Seoul)"},{"key":"8806_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079325","volume":"8","author":"S Arndt","year":"2013","unstructured":"Arndt S, Unger P, Wacker E, Shimizu T, Heinlin J, Li Y-F, et al. Cold atmospheric plasma (CAP) changes gene expression of key molecules of the wound healing machinery and improves wound healing in vitro and in vivo. PLoS One. 2013;8: e79325. https:\/\/doi.org\/10.1371\/journal.pone.0079325.","journal-title":"PLoS One"},{"key":"8806_CR26","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/exd.12043","volume":"21","author":"M Marschewski","year":"2012","unstructured":"Marschewski M, Hirschberg J, Omairi T, H\u00f6fft O, Vi\u00f6l W, Emmert S, et al. Electron spectroscopic analysis of the human lipid skin barrier: cold atmospheric plasma-induced changes in lipid composition. Exp Dermatol. 2012;21:921\u20135. https:\/\/doi.org\/10.1111\/exd.12043.","journal-title":"Exp Dermatol"},{"key":"8806_CR27","doi-asserted-by":"publisher","unstructured":"Dejonckheere CS, Torres-Crigna A, Layer JP, Layer K, Wiegreffe S, Sarria GR, et al. Non-invasive physical plasma for preventing radiation dermatitis in breast cancer: a first-in-human feasibility study. Pharmaceutics 2022;14. https:\/\/doi.org\/10.3390\/pharmaceutics14091767.","DOI":"10.3390\/pharmaceutics14091767"},{"key":"8806_CR28","doi-asserted-by":"publisher","unstructured":"Dejonckheere CS, Layer JP, Nour Y, Glasmacher A, Wiegreffe S, Fuhrmann A, et al. Non-invasive physical plasma for preventing radiation dermatitis in breast cancer: results from an intrapatient-randomised double-blind placebo-controlled trial. Clin Transl Radiat Oncol. 2023:100699. https:\/\/doi.org\/10.1016\/j.ctro.2023.100699.","DOI":"10.1016\/j.ctro.2023.100699"},{"key":"8806_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.radonc.2014.11.030","volume":"114","author":"B Offersen","year":"2015","unstructured":"Offersen B, Boersma LJ, Kirkove C, Hol S, Aznar MC, Biete Sola A, et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol. 2015;114:3\u201310. https:\/\/doi.org\/10.1016\/j.radonc.2014.11.030.","journal-title":"Radiother Oncol"},{"key":"8806_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S1470-2045(14)71156-8","volume":"16","author":"H Bartelink","year":"2015","unstructured":"Bartelink H, Maingon P, Poortmans P, Weltens C, Fourquet A, Jager J, et al. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. Lancet Oncol. 2015;16:47\u201356. https:\/\/doi.org\/10.1016\/S1470-2045(14)71156-8.","journal-title":"Lancet Oncol"},{"key":"8806_CR31","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ijrobp.2022.07.2320","volume":"114","author":"FA Vicini","year":"2022","unstructured":"Vicini FA, Winter K, Freedman GM, Arthur DW, Hayman JA, Rosenstein BS, et al. NRG RTOG 1005: a phase III trial of hypo fractionated whole breast irradiation with concurrent boost vs. conventional whole breast irradiation plus sequential boost following lumpectomy for high risk early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2022;114:S1. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.07.2320.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"8806_CR32","unstructured":"Common terminology criteria for adverse events (CTCAE) version 5.0 n.d. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf."},{"key":"8806_CR33","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.12968\/bjon.1999.8.19.1305","volume":"8","author":"R Noble-Adams","year":"1999","unstructured":"Noble-Adams R. Radiation-induced skin reactions. 3: evaluating the RISRAS. Br J Nurs. 1999;8:1305\u201312. https:\/\/doi.org\/10.12968\/bjon.1999.8.19.1305.","journal-title":"Br J Nurs"},{"key":"8806_CR34","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00066-005-1345-3","volume":"181","author":"F Momm","year":"2005","unstructured":"Momm F, Bartelt S, Haigis K, Grosse-Sender A, Witucki G. Spectrophotometric skin measurements correlate with EORTC\/RTOG-common toxicity criteria. Strahlenther Onkol. 2005;181:392\u20135. https:\/\/doi.org\/10.1007\/s00066-005-1345-3.","journal-title":"Strahlenther Onkol"},{"key":"8806_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cancers12092444","volume":"12","author":"AMC B\u00f6hner","year":"2020","unstructured":"B\u00f6hner AMC, Koch D, Schmeel FC, R\u00f6hner F, Schoroth F, Sarria GR, et al. Objective evaluation of risk factors for radiation dermatitis in whole-breast irradiation using the spectrophotometric L*a*b* colour-space. Cancers (Basel). 2020;12:12. https:\/\/doi.org\/10.3390\/cancers12092444.","journal-title":"Cancers (Basel)"},{"key":"8806_CR36","volume-title":"Nonparametrics: statistical methods based on ranks","author":"EL Lehmann","year":"1998","unstructured":"Lehmann EL, D\u2019Abrera HJM. Nonparametrics: statistical methods based on ranks. Saddle River: Prentice Hall; 1998."},{"key":"8806_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.radonc.2014.01.005","volume":"110","author":"PM Herst","year":"2014","unstructured":"Herst PM, Bennett NC, Sutherland AE, Peszynski RI, Paterson DB, Jasperse ML. Prophylactic use of Mepitel Film prevents radiation-induced moist desquamation in an intra-patient randomised controlled clinical trial of 78 breast cancer patients. Radiother Oncol. 2014;110:137\u201343. https:\/\/doi.org\/10.1016\/j.radonc.2014.01.005.","journal-title":"Radiother Oncol"},{"key":"8806_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.tipsro.2018.05.004","volume":"7","author":"PK M\u00f8ller","year":"2018","unstructured":"M\u00f8ller PK, Olling K, Berg M, Hab\u00e6k I, Haislund B, Iversen A-M, et al. Breast cancer patients report reduced sensitivity and pain using a barrier film during radiotherapy \u2013 a Danish intra-patient randomized multicentre study. Tech Innov Patient Support Radiat Oncol. 2018;7:20\u20135. https:\/\/doi.org\/10.1016\/j.tipsro.2018.05.004.","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"8806_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12134212","volume":"12","author":"CS Dejonckheere","year":"2023","unstructured":"Dejonckheere CS, Abramian A, Lindner K, Bachmann A, Layer K, Anzb\u00f6ck T, et al. Objective, clinician- and patient-reported evaluation of late toxicity following adjuvant radiation for early breast cancer: long-term follow-up results of a randomised series. J Clin Med. 2023;12: 4212.","journal-title":"J Clin Med"},{"key":"8806_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12227195","volume":"12","author":"CS Dejonckheere","year":"2023","unstructured":"Dejonckheere CS, Lindner K, Bachmann A, Abramian A, Layer K, Anzb\u00f6ck T, et al. Do barrier films impact long-term skin toxicity following whole-breast irradiation\u202f? Objective follow-up of two randomised trials. J Clin Med. 2023;12: 7195.","journal-title":"J Clin Med"},{"key":"8806_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2021.100403","volume":"28","author":"T Behroozian","year":"2021","unstructured":"Behroozian T, Milton L, Li N, Zhang L, Lou J, Karam I, et al. Predictive factors associated with radiation dermatitis in breast cancer. Cancer Treat Res Commun. 2021;28: 100403. https:\/\/doi.org\/10.1016\/j.ctarc.2021.100403.","journal-title":"Cancer Treat Res Commun"},{"key":"8806_CR42","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.21873\/anticanres.11960","volume":"37","author":"F Haruna","year":"2017","unstructured":"Haruna F, Lipsett A, Marignol L. Topical management of acute radiation dermatitis in breast cancer patients: a systematic review and meta-analysis. Anticancer Res. 2017;37:5343\u201353. https:\/\/doi.org\/10.21873\/anticanres.11960.","journal-title":"Anticancer Res"},{"key":"8806_CR43","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s00520-023-07820-5","volume":"31","author":"S Tam","year":"2023","unstructured":"Tam S, Zhou G, Trombetta M, Caini S, Ryan Wolf J, van den Hurk C, et al. Topical corticosteroids for the prevention of severe radiation dermatitis: a systematic review and meta-analysis. Support Care Cancer. 2023;31:382. https:\/\/doi.org\/10.1007\/s00520-023-07820-5.","journal-title":"Support Care Cancer"},{"key":"8806_CR44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.radonc.2021.03.020","volume":"159","author":"T Behroozian","year":"2021","unstructured":"Behroozian T, Milton L, Zhang L, Lou J, Karam I, Lam E, et al. How do patient-reported outcomes compare with clinician assessments? A prospective study of radiation dermatitis in breast cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2021;159:98\u2013105. https:\/\/doi.org\/10.1016\/j.radonc.2021.03.020.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"8806_CR45","doi-asserted-by":"publisher","unstructured":"Dejonckheere CS, Stope MB, Schmeel LC. Concise review of non-invasive physical plasma as a promising treatment option for radiation injuries of the skin. 2023. p. 3\u20135. https:\/\/doi.org\/10.1111\/wrr.13077.","DOI":"10.1111\/wrr.13077"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08806-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-08806-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08806-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T09:18:29Z","timestamp":1742375909000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-08806-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8806"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-08806-w","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"4 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study will be conducted in accordance with the Declaration of Helsinki and following the scientific quality standards as per the Good Clinical Practice (GCP) guidelines. The protocol was approved by the Institutional Review Board of the University Bonn in On December 21st, 2023 (377\/23\u2212EP). Patients will only be enrolled upon providing informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that no funds, grants, or other support were received during the preparation of this manuscript. M.B.S. is the founder and CEO of 5\u2019-TOP-3\u2019 Physical Plasma Medicine. There are no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"97"}}